Home／CELL THERAPY／Timing Precision GTP Cell Processing Center
Timing Precision GTP Cell Processing Center | Immune Cells, Stem Cells, CDMO Services
Driven by the trends of an aging population and advancements in precision medicine, Timing Pharmaceutical (Stock Code: 6659) has built upon its foundation as a GMP-certified TCM manufacturer to establish the Timing Precision GTP Cell Processing Center, integrating our existing NK and NKT cell cryopreservation and processing technologies. The center has assembled an elite team of experts, including professionals with Ph.D. and Master's degrees, specializing in Natural Killer (NK) cell expansion technology.
Authorized under the Regulations Governing Specific Medical Technology, our autologous Natural Killer (NK) cell therapy is indicated for Stage IV solid tumors, including:
The center specializes in Contract Development and Manufacturing Organization (CDMO) services, equipped with multi-modular cell processing rooms, cryopreservation rooms, and Quality Control (QC) laboratories. High-specification cell products are meticulously manufactured, tailored to the specific contract manufacturing, quality inspection, and clinical requirements of various immune cell and stem cell products.
We actively collaborate with leading domestic medical institutions to submit CIK and NK cell therapy project applications in accordance with the Regulations Governing Specific Medical Technology. Our partnering institutions include Chung Shan Hospital (Taipei), Fu Jen Catholic University Hospital, Cheng Ching Hospital (Chung Kang Branch), Tai-An Hospital (Shuang-Shih Branch), and Chung Shan Medical University Hospital. Furthermore, to strengthen our commitment to research and development, we have partnered with Far Eastern Memorial Hospital and Fu Jen Catholic University Hospital to jointly develop TIL (Tumor-Infiltrating Lymphocyte) cell therapy technology.
Features & Advantages
01
For medical services, our collaboration with the Chung Shan Timing Cell Therapy Center at Chung Shan Hospital (Taipei) has been officially approved under the Regulations Governing Specific Medical Technology.
02
Built on a solid clinical foundation, we have successfully obtained Investigational New Drug (IND) approval from the Taiwan Food and Drug Administration (TFDA) for human clinical trials involving Natural Killer (NK) cells.
03
Pioneering innovative translational applications, we are engaged in the joint research and development of Tumor-Infiltrating Lymphocyte (TIL) cell therapies in collaboration with Far Eastern Memorial Hospital.
04
We are firmly committed to delivering comprehensive Contract Development and Manufacturing Organization (CDMO) services, supported by our highly specialized manufacturing processes and professional Quality Control (QC) team.
05
To meet the evolving demands of clinical development and future medical advancements, the center provides comprehensive contract cell cryopreservation services.
06
Timing Precision Testing Laboratory has obtained ISO/IEC 17025 accreditation from the Taiwan Accreditation Foundation (TAF) (Accreditation No.: 3982).
07
Timing Precision Cell Processing Center has obtained the Good Tissue Practice (GTP) compliance accreditation for human cell and tissue processing (Accreditation No.: TP112C032).
08
Secured approval for the first project in Taiwan utilizing Natural Killer (NK) cells for Phase I-III treatment of solid tumors.
詳細服務規格
GTP LAB Timing Precision GTP Cell Processing Center
Regulations Governing Specific Medical Technology Timing-NK® Natural Killer Cells
Regulations Governing Specific Medical Technology Timing-TIL® Tumor-Infiltrating Lymphocytes
Regulations Governing Specific Medical Technology Timing-CIK® Cytokine-Induced Killer Cells
Contract Research Timing-MSC® Mesenchymal Stem Cells
Contract Services
-
Regulations Governing Specific Medical Technology (特管辦法)
-
Compassionate Use / Compassionate Treatment (恩慈治療)
-
Processing / Preparation (製備)
-
Testing / Inspection / Quality Control (QC) (檢驗)
-
Cryopreservation (凍存)
Contract Research Timing-EXO® Exosomes
